Expert Opinion on Therapeutic Patents

Functional imaging and the pharmaceutical industry
pp. 1165-1171(7)
Author: Peters A.

SmithKline Beecham: analysis of patenting 1995 - 1998
pp. 1173-1183(11)
Author: Adams S.

Patenting of therapeutics for obesity and nutritional disease
pp. 1185-1196(12)
Author: Nelson J.

Recent advances in S-adenosyl-L-homocysteine hydrolase inhibitors and their potential clinical applications
pp. 1197-1206(10)
Authors: Yuan C-S.; Saso Y.; Lazarides E.; Borchardt R.T.; Robins M.J.

Marine natural products as therapeutic agents
pp. 1207-1222(16)
Authors: Kerr R.G.; Kerr S.S.

Therapeutic approaches to Type 2 diabetes mellitus
pp. 1223-1236(14)
Authors: Rose M.L.; Paulik M.A.; Lenhard J.M.

Anti-integrins as a potential therapeutic target in angiogenesis
pp. 1237-1248(12)
Author: Mousa S.A.

Development in hepatitis C during 1997 - 1999
pp. 1249-1262(14)
Authors: Poordad F.; Gish R.

Inhibitors of protein prenylation 1999
pp. 1263-1280(18)
Author: Williams T.M.

Annotated Patent Selections
pp. 1281-1292(12)

A series of hydrazone derivatives that elevate HDL-cholesterol
pp. 1293-1298(6)

Small molecules useful in the treatment of inflammatory disease
pp. 1299-1302(4)

Arylsulphonamide hydroxamic acids as potent inhibitors of MMP-13
pp. 1303-1307(5)